A dose‐ranging, placebo‐controlled, pilot trial of Acotiamide in patients with functional dyspepsia
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Abstract Impaired gastric accommodation, hypersensitivity to distension and delayed gastric emptying are major pathophysiological mechanisms in functional dyspepsia (FD). Acotiamide (Z‐338) was well‐tolerated in healthy volunteers. To determine the effect of three doses of Acotiamide on major pathophysiological mechanisms, symptoms, quality of life (QOL) and safety in functional dyspeptics. A phase IIa, randomized, double‐blind, placebo‐controlled study (14, 21 and 28 days, respectively, for run‐in, study drug administration and follow‐up). Gastric accommodation, sensitivity to distension and gastric emptying were assessed by barostat and 13 C breath test, symptoms by daily diary cards and QOL by SF‐36. A total of 71 patients were enrolled (62 evaluable). There was no effect on gastric emptying and sensitivity to distension. 300 mg was better than placebo for meal accommodation (P = 0.024). 100 mg was better than placebo at week 2 for upper abdominal bloating (P = 0.001) and overall symptom score (P = 0.022), and at week 3 for bloating (P = 0.008) and heartburn (P = 0.041). 100 mg was also better than placebo for QOL (physical function) (P = 0.003). Acotiamide was safe and well‐tolerated in patients with FD. The involved mechanism could at least in part depend on an effect on meal‐induced accommodation. 100 mg Acotiamide exhibited the potential to improve FD symptoms and QOL. Further studies are indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Gastroduodenal Disorders
Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., & Stanghellini, V. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.059 · Cited by 2,418
Self-citationPrather, C. M., Camilleri, M., Zinsmeister, A. R., McKinzie, S., & Thomforde, G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70251-4 · Cited by 410
Cited by
Functional dyspepsia—symptoms, definitions and validity of the Rome III criteria
Tack, J., & Talley, N. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.14 · Cited by 276
Self-citationReview article: current treatment options and management of functional dyspepsia
Lacy, B. E., Talley, N. J., Locke, G. R., Bouras, E. P., DiBaise, J. K., El‐Serag, H. B., Abraham, B. P., Howden, C. W., Moayyedi, P., & Prather, C. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05128.x · Cited by 192
Dyspepsia: Organic Versus Functional
Oustamanolakis, P., & Tack, J. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318241b335 · Cited by 146
Self-citationSchmulson, M., & Chang, L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04637.x · Cited by 70
“underlying mechanism responsible for the effect on bloating needs to be determined.(70) Two serious adverse events reported with the 50 mg three times daily dosage were biliary colic and angina pectoris.”
Background
Metadata
- Authors
- Tack, J., Masclee, A., Heading, R., Berstad, A., Piessevaux, H., Popiela, T., Vandenberghe, A., & Kato, H.
- Venue
- Neurogastroenterology & Motility
- Publisher
- Wiley
- Published
- 2009-02-19
- Volume
- 21
- Issue
- 3
- Pages
- 272-280
- ISSN
- 1350-1925 (ISSN-L)
- 1365-2982
- OpenAlex
- W1978204320
- Cited by
- 101
- References
- 2
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A dose‐ranging, placebo‐controlled, pilot trial of Acotiamide in patients with functional dyspepsia. https://app.cochat.ai/papers/10.1111/j.1365-2982.2009.01261.x
- The paper
- Tack, J., Masclee, A., Heading, R., Berstad, A., Piessevaux, H., Popiela, T., Vandenberghe, A., & Kato, H. (2009). A dose‐ranging, placebo‐controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Neurogastroenterology & Motility. https://doi.org/10.1111/j.1365-2982.2009.01261.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.